User menu

Antioxidant effects and the therapeutic mode of action of calcium channel blockers in hypertension and atherosclerosis.

Bibliographic reference Godfraind, Theophile. Antioxidant effects and the therapeutic mode of action of calcium channel blockers in hypertension and atherosclerosis.. In: Philosophical transactions of the Royal Society of London. Series B, Biological sciences, Vol. 360, no. 1464, p. 2259-72 (2005)
Permanent URL http://hdl.handle.net/2078.1/10409
  1. Arribas, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 19, 517 (1999)
  2. Asano Masahisa, Matsuda Tomohiro, Hayakawa Makie, Ito Kaoru M., Ito Katsuaki, Increased resting Ca2+ maintains the myogenic tone and activates K+ channels in arteries from young spontaneously hypertensive rats, 10.1016/0922-4106(93)90198-i
  3. Asano, Journal of Pharmacology and Experimental Therapeutics, 275, 775 (1995)
  4. Barton Matthias, Haudenschild Christian C, Endothelium and Atherogenesis: Endothelial Therapy Revisited : , 10.1097/00005344-200111002-00007
  5. Barton M., Haudenschild C. C., d'Uscio L. V., Shaw S., Munter K., Luscher T. F., Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice, 10.1073/pnas.95.24.14367
  6. Berkels R., Egink G., Marsen T. A., Bartels H., Roesen R., Klaus W., Nifedipine Increases Endothelial Nitric Oxide Bioavailability by Antioxidative Mechanisms, 10.1161/01.hyp.37.2.240
  7. Bonthu S., Heistad D. D., Chappell D. A., Lamping K. G., Faraci F. M., Atherosclerosis, Vascular Remodeling, and Impairment of Endothelium-Dependent Relaxation in Genetically Altered Hyperlipidemic Mice, 10.1161/01.atv.17.11.2333
  8. Catterall William A., Structure and Regulation of Voltage-Gated Ca2+ Channels, 10.1146/annurev.cellbio.16.1.521
  9. Cox Robert H, Rusch Nancy J, New Expression Profiles of Voltage-gated Ion Channels in Arteries Exposed to High Blood Pressure, 10.1038/sj.mn.7800140
  10. Cristofori Patrizia, Lanzoni Anna, Quartaroli Mauro, Pastorino Antonio M., Zancanaro Carlo, Cominacini Luciano, Gaviraghi Giovanni, Turton John, The calcium-channel blocker lacidipine reduces the development of atherosclerotic lesions in the apoE-deficient mouse : , 10.1097/00004872-200018100-00010
  11. Cristofori Patrizia, Crivellente Federica, Campagnola Mario, Pasini Anna Fratta, Garbin Ulisse, Rigoni Anna, Tosetti Maria, Turton John, Faustinelli Ivo, Cominacini Luciano, Reduced progression of atherosclerosis in apolipoprotein E-deficient mice treated with lacidipine is associated with a decreased susceptibility of low-density lipoprotein to oxidation : Lacidipine in apoE knock-out mice, 10.1111/j.0959-9673.2004.00375.x
  12. The Journal of Physiology, 161, 90 (1961)
  13. d'Uscio L. V., Baker T. A., Mantilla C. B., Smith L., Weiler D., Sieck G. C., Katusic Z. S., Mechanism of Endothelial Dysfunction in Apolipoprotein E-Deficient Mice, 10.1161/01.atv.21.6.1017
  14. Ebashi S., The Croonian Lecture, 1979: Regulation of Muscle Contraction, 10.1098/rspb.1980.0024
  15. HIGUCHI AKIHIRO, HAYASHI TAKASHI, BAMBA KENZOU, HAGIWARA HIROMI, HIROSE SHIGEHISA, PUTATIVE LIGAND-BINDING SITES OF THE TYPE C ATRIAL NATRIURETIC PEPTIDE RECEPTOR , 10.2220/biomedres.14.1
  16. Edman, Nature; Physical Science (London), 190, 350 (1961)
  17. Edman K. A. P., Schild H. O., The need for calcium in the contractile responses induced by acetylcholine and potassium in the rat uterus, 10.1113/jphysiol.1962.sp006897
  18. 25, 533 (2000)
  19. Evans D. H. L., Schild H. O., Thesleff S., Effects of drugs on depolarized plain muscle, 10.1113/jphysiol.1958.sp006072
  20. Fleckenstein, Pfl  gers Archiv : European journal of physiology, 307, R25 (1969)
  21. Fox A P, Nowycky M C, Tsien R W, Kinetic and pharmacological properties distinguishing three types of calcium currents in chick sensory neurones., 10.1113/jphysiol.1987.sp016864
  22. Fox A P, Nowycky M C, Tsien R W, Single-channel recordings of three types of calcium channels in chick sensory neurones., 10.1113/jphysiol.1987.sp016865
  23. Godfraind, Journal of Pharmacology and Experimental Therapeutics, 224, 443 (1983)
  24. GODFRAIND T., KABA A., Blockade or reversal of the contraction induced by calcium and adrenaline in depolarized arterial smooth muscle, 10.1111/j.1476-5381.1969.tb08010.x
  25. Godfraind, British journal of pharmacology, 35, P354 (1969)
  26. Godfraind, Circulation Research, 52, I81 (1983)
  27. Godfraind, Th  rapie, 23, 1209 (1968)
  28. Godfraind, British journal of pharmacology, 28, 93 (1966)
  29. Godfraind, Archives internationales de pharmacodynamie et de th  rapie, 172, 235 (1968)
  30. Godfraind, Pharmacological Reviews, 38, 321 (1986)
  31. Godfraind T., Kazda S., Wibo M., Effects of a chronic treatment by nisoldipine, a calcium antagonistic dihydropyridine, on arteries of spontaneously hypertensive rats, 10.1161/01.res.68.3.674
  32. Godfraind, Bulletin de l'Academie Nationale de Medecine, 181, 289 (1997)
  33. Griendling K. K., Sorescu D., Ushio-Fukai M., NAD(P)H Oxidase : Role in Cardiovascular Biology and Disease, 10.1161/01.res.86.5.494
  34. Hayek T., Oiknine J., Brook J.G., Aviram M., Increased Plasma and Lipoprotein Lipid Peroxidation in apo E-Deficient Mice, 10.1006/bbrc.1994.1883
  35. 29, 15 (1947)
  36. Henry, The American journal of cardiology, 66, 3I (1990)
  37. Hess P., Calcium channel selectivity for divalent and monovalent cations. Voltage and concentration dependence of single channel current in ventricular heart cells, 10.1085/jgp.88.3.293
  38. Hsu Yung-Ho, Chen Jin-Jer, Chang Nen-Chung, Chen Cheng-Hsien, Liu Ju-Chi, Chen Tso-Hsiao, Jeng Cherng-Jye, Chao Hung-Hsing, Cheng Tzu-Hurng, Role of Reactive Oxygen Species-Sensitive Extracellular Signal-Regulated Kinase Pathway in Angiotensin II-Induced Endothelin-1 Gene Expression in Vascular Endothelial Cells, 10.1159/000076247
  39. Hwang J., Pulsatile Versus Oscillatory Shear Stress Regulates NADPH Oxidase Subunit Expression: Implication for Native LDL Oxidation, 10.1161/01.res.0000104087.29395.66
  40. Jackson W. F., Ion Channels and Vascular Tone, 10.1161/01.hyp.35.1.173
  41. Jiang Fan, Gibson Angela P., Dusting Gregory J., Endothelial dysfunction induced by oxidized low-density lipoproteins in isolated mouse aorta: a comparison with apolipoprotein-E deficient mice, 10.1016/s0014-2999(01)01140-2
  42. JPN J ZOOL, 10, 469 (1943)
  43. Karaki Hideaki, Historical techniques: Cytosolic Ca2+ and contraction in smooth muscle, 10.1016/j.tips.2004.05.008
  44. Karaki, Pharmacological Reviews, 49, 157 (1997)
  45. Keidar Shlomo, Attias Judith, Coleman Raymond, Wirth Klaus, Schölkens Bernward, Hayek Tony, Attenuation of Atherosclerosis in Apolipoprotein E-Deficient Mice by Ramipril is Dissociated from Its Antihypertensive Effect and from Potentiation of Bradykinin : , 10.1097/00005344-200001000-00008
  46. Knorr, Archives internationales de pharmacodynamie et de th  rapie, 269, 316 (1984)
  47. British journal of pharmacology, 126, 129P (1999)
  48. Krenek P., Salomone S., Kyselovic J., Wibo M., Morel N., Godfraind T., Lacidipine Prevents Endothelial Dysfunction in Salt-Loaded Stroke-Prone Hypertensive Rats, 10.1161/01.hyp.37.4.1124
  49. Kyselovic Jan, Morel Nicole, Wibo Maurice, Godfraind Théophile, Prevention of salt-dependent cardiac remodeling and enhanced gene expression in stroke-prone hypertensive rats by the long-acting calcium channel blocker lacidipine : , 10.1097/00004872-199816100-00017
  50. Kyselovic Jan, Krenek Peter, Wibo Maurice, Godfraind Théophile, Effects of amlodipine and lacidipine on cardiac remodelling and renin production in salt-loaded stroke-prone hypertensive rats, 10.1038/sj.bjp.0704398
  51. Author Index (ABSTRACTS DPG), 10.1007/s00424-003-1016-0
  52. Fundamental & clinical pharmacology, 18, 75 (2004)
  53. Kyselovic J., Calcium Channel Blocker Inhibits Western-Type Diet-Evoked Atherosclerosis Development in ApoE-Deficient Mice, 10.1124/jpet.105.089847
  54. Journal of cardiovascular pharmacology, 4, S319 (1982)
  55. Libby, Annals of the New York Academy of Sciences, 748, 158 (1995)
  56. Journal of cardiovascular pharmacology, 25, S9 (1995)
  57. Liu Y., Pleyte K., Knaus H.-G., Rusch N. J., Increased Expression of Ca2+-Sensitive K+ Channels in Aorta of Hypertensive Rats, 10.1161/01.hyp.30.6.1403
  58. Lu X., Kassab G. S., Nitric oxide is significantly reduced inex vivoporcine arteries during reverse flow because of increased superoxide production : NO is reduced during reverse flow, 10.1113/jphysiol.2004.075218
  59. 165, 191 (2002)
  60. Messerli Franz H., Salt : A Perpetrator of Hypertensive Target Organ Disease?, 10.1001/archinte.1997.00440420077006
  61. Morel, Journal of Pharmacology and Experimental Therapeutics, 243, 711 (1987)
  62. Morel Nicole, Godfraind Théophile, Selective modulation by membrane potential of the interaction of some calcium entry blockers with calcium channels in rat mesenteric artery, 10.1111/j.1476-5381.1988.tb16571.x
  63. Morel Nicole, Godfraind Theophile, Pharmacological properties of voltage-dependent calcium channels in functional microvessels isolated from rat brain, 10.1007/bf00167047
  64. Morel, Journal of cardiovascular pharmacology, 24, 524 (1994)
  65. Muller D. N., Fischli W., Clozel J.-P., Hilgers K. F., Bohlender J., Menard J., Busjahn A., Ganten D., Luft F. C., Local Angiotensin II Generation in the Rat Heart : Role of Renin Uptake, 10.1161/01.res.82.1.13
  66. Nakashima Y., Plump A. S., Raines E. W., Breslow J. L., Ross R., ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree, 10.1161/01.atv.14.1.133
  67. Nakazono K., Watanabe N., Matsuno K., Sasaki J., Sato T., Inoue M., Does superoxide underlie the pathogenesis of hypertension?, 10.1073/pnas.88.22.10045
  68. Napoli C., Salomone S., Godfraind T., Palinski W., Capuzzi D. M., Palumbo G., D'Armiento F. P., Donzelli R., de Nigris F., Capizzi R. L., Mancini M., Gonnella J. S., Bianchi A., Chan P. H., 1,4-Dihydropyridine Calcium Channel Blockers Inhibit Plasma and LDL Oxidation and Formation of Oxidation-Specific Epitopes in the Arterial Wall and Prolong Survival in Stroke-Prone Spontaneously Hypertensive Rats   Editorial Comment, 10.1161/01.str.30.9.1907
  69. Nowycky Martha C., Fox Aaron P., Tsien Richard W., Three types of neuronal calcium channel with different calcium agonist sensitivity, 10.1038/316440a0
  70. Ohkawa Hiroshi, Ohishi Nobuko, Yagi Kunio, Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction, 10.1016/0003-2697(79)90738-3
  71. Plump Andrew S., Smith Jonathan D., Hayek Tony, Aalto-Setälä Katriina, Walsh Annemarie, Verstuyft Judy G., Rubin Edward M., Breslow Jan L., Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells, 10.1016/0092-8674(92)90362-g
  72. Prasad A., Tupas-Habib T., Schenke W. H., Mincemoyer R., Panza J. A., Waclawin M. A., Ellahham S., Quyyumi A. A., Acute and Chronic Angiotensin-1 Receptor Antagonism Reverses Endothelial Dysfunction in Atherosclerosis, 10.1161/01.cir.101.20.2349
  73. Praticò Domenico, Tangirala Rajendra K., Rader Daniel J., Rokach Joshua, FitzGerald Garret A., Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice, 10.1038/2685
  74. Pratt P. F., Bonnet S., Ludwig L. M., Bonnet P., Rusch N. J., Upregulation of L-Type Ca2+ Channels in Mesenteric and Skeletal Arteries of SHR, 10.1161/01.hyp.0000025877.23309.36
  75. Ringer Sydney, A further Contribution regarding the influence of the different Constituents of the Blood on the Contraction of the Heart, 10.1113/jphysiol.1883.sp000120
  76. Salomone, Naunyn-Schmiedeberg's archives of pharmacology, 344, 698 (1991)
  77. Salomone Salvatore, Dessy Chantal, Morel Nicole, Godfraind Theophile, Inhibition by bosentan, an endothelin antagonist, of the hypersensitivity to Ca2+ channel activator evoked by salt-loading in basilar artery of stroke-prone spontaneously hypertensive rats, 10.1016/0024-3205(96)00463-8
  78. Salomone, British journal of pharmacology, 121, 1051 (1997)
  79. 161, 327 (2002)
  80. Schiffrin Ernesto L, Beyond blood pressure: the endothelium and atherosclerosis progression*, 10.1016/s0895-7061(02)03006-6
  81. Sher, The FASEB Journal, 5, 2677 (1991)
  82. Somlyo Andrew P., Somlyo Avril V., Signal transduction and regulation in smooth muscle, 10.1038/372231a0
  83. Stiles, American Journal of Physiology -- Legacy Content, 5, 338 (1901)
  84. Thomas S. R., Leichtweis S. B., Pettersson K., Croft K. D., Mori T. A., Brown A. J., Stocker R., Dietary Cosupplementation With Vitamin E and Coenzyme Q10 Inhibits Atherosclerosis in Apolipoprotein E Gene Knockout Mice, 10.1161/01.atv.21.4.585
  85. Toikka J. O., Laine H., Ahotupa M., Haapanen A., Viikari J. S. A., Hartiala J. J., Raitakari O. T, Increased Arterial Intima-Media Thickness and In Vivo LDL Oxidation in Young Men With Borderline Hypertension, 10.1161/01.hyp.36.6.929
  86. Tsien Richard W., Tsien Roger Y., Calcium Channels, Stores, and Oscillations, 10.1146/annurev.cb.06.110190.003435
  87. Journal of cardiovascular pharmacology, 30, S28 (1997)
  88. Weiss D., Kools J. J., Taylor W. R., Angiotensin II-Induced Hypertension Accelerates the Development of Atherosclerosis in ApoE-Deficient Mice, 10.1161/01.cir.103.3.448
  89. YUKISADA NORIKO, EBASHI FUMIKO, ROLE OF CALCIUM IN DRUG ACTION ON SMOOTH MUSCLE, 10.1254/jjp.11.46
  90. Zalba G., Jose G. S., Moreno M. U., Fortuno M. A., Fortuno A., Beaumont F. J., Diez J., Oxidative Stress in Arterial Hypertension: Role of NAD(P)H Oxidase, 10.1161/hy1201.099611